Double-digit growth expected for hemodynamic patient monitoring market

The trend towards minimally and noninvasive techniques in the hemodynamic and neurological segments, combined with decreasing hospital costs, is expected to result in double-digit annual market growth in these segments over the next five years, according to a market report from Millennium Research Group (MRG).

Critical care areas of hospitals can represent a substantial expense with high staff-to-patient ratios and frequent testing of patients required, MRG said. The desire to contain hospital costs is a strong driver of the noninvasive hemodynamic monitoring market. According to the report, traditional methods of hemodynamic monitoring are extremely expensive, with catheter insertions performed only by skilled physicians.

However, the report noted that minimally invasive and noninvasive devices are easier to use, and many can be placed by a nurse. The ease-of-use allows the monitoring of large patient volumes while containing staffing costs, contributing to the popularity of less invasive hemodynamic monitoring techniques through 2013.

“End-user feedback gathered for this report gave us plenty of insight into how ICU nurses feel and are dealing with trends favoring less invasive monitoring technologies and cost savings,” said Sarah Leonard, analyst at MRG. “When asked what characteristics are most important in a patient monitor, critical care nurses agree that ease-of-use is the most important issue.”

The report said that substantial opportunities for growth also exist for neurological advanced monitoring technologies due to their ability to indicate complications and potential problems well in advance of cerebral swelling.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.